Alpha-helical cationic antimicrobial peptides: relationships of structure and function
- First Online:
- 702 Downloads
Antimicrobial peptides (AMPs), with their extraordinary properties, such as broad-spectrum activity, rapid action and difficult development of resistance, have become promising molecules as new antibiotics. Despite their various mechanisms of action, the interaction of AMPs with the bacterial cell membrane is the key step for their mode of action. Moreover, it is generally accepted that the membrane is the primary target of most AMPs, and the interaction between AMPs and eukaryotic cell membranes (causing toxicity to host cells) limits their clinical application. Therefore, researchers are engaged in reforming or de novo designing AMPs as a ‘singleedged sword’ that contains high antimicrobial activity yet low cytotoxicity against eukaryotic cells. To improve the antimicrobial activity of AMPs, the relationship between the structure and function of AMPs has been rigorously pursued. In this review, we focus on the current knowledge of α-helical cationic antimicrobial peptides, one of the most common types of AMPs in nature.
Keywordsantimicrobial peptides mechanism of action peptide structure antimicrobial activity
Unable to display preview. Download preview PDF.
- Brogden, K.A. (2005). Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev 3, 238–250.Google Scholar
- Dathe, M., Schumann, M., Wieprecht, T., Winkler, A., Beyermann, M., Krause, E., Matsuzaki, K., Murase, O., and Bienert, M. (1996). Peptide helicity and membrane surface charge modulate the balance of electrostatic and hydrophobic interactions with lipid bilayers and biological membranes. Biochemistry 35, 12612–12622.CrossRefGoogle Scholar
- Dathe, M., Wieprecht, T., Nikolenko, H., Handel, L., Maloy, W.L., MacDonald, D.L., Beyermann, M., and Bienert, M. (1997). Hydrophobicity, hydrophobic moment and angle subtended by charged residues modulate antibacterial and haemolytic activity of amphipathic helical peptides. Febs Lett 403, 208–212.CrossRefGoogle Scholar
- Giuliani, A., Pirri, G., and Nicoletto, S.F. (2007). Antimicrobial peptides: an overview of a promising class of therapeutics. Cent Eur J Biol 2, 1–33.Google Scholar
- Konno, K., Rangel, M., Oliveira, J.S., Dos Santos Cabrera, M.P., Fontana, R., Hirata, I.Y., Hide, I., Nakata, Y., Mori, K., Kawano, M., et al. (2007). Decoralin, a novel linear cationic alpha-helical peptide from the venom of the solitary eumenine wasp Oreumenes decoratus. Peptides 28, 2320–2327.CrossRefGoogle Scholar
- Lee, D.G., Kim, H.N., Park, Y.K., Kim, H.K., Choi, B.H., Choi, C.H., and Hahm, K.S. (2002). Design of novel analogue peptides with potent antibiotic activity based on the antimicrobial peptide, HP (2–20), derived from N-terminus of Helicobacter pylori ribosomal protein L1. Bba-Proteins Proteom 1598, 185–194.CrossRefGoogle Scholar
- Marshall, S.H., and Arenas, G. (2003). Antimicrobial peptides: A natural alternative to chemical antibiotics and a potential for applied biotechnology. Electron J Biotechn 6, 271–284.Google Scholar
- Resende, J.M., Moraes, C.M., Munhoz, V.H., Aisenbrey, C., Verly, R. M., Bertani, P., Cesar, A., Pilo-Veloso, D., and Bechinger, B. (2009). Membrane structure and conformational changes of the antibiotic heterodimeric peptide distinctin by solid-state NMR spectroscopy. Proc Natl Acad Sci U S A 106, 16639–16644.CrossRefGoogle Scholar
- Wakabayashi, H., Matsumoto, H., Hashimoto, K., Teraguchi, S., Takase, M., and Hayasawa, H. (1999). N-acylated and D enantiomer derivatives of a nonamer core peptide of lactoferricin B showing improved antimicrobial activity. Antimicrob Agents Ch 43, 1267–1269.Google Scholar